Assessing artificial intelligence enabled liquid‐based cytology for triaging HPV‐positive women: a population‐based cross‐sectional study

Introduction Cytology‐based triaging is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but it suffers from subjectivity and a lack of sensitivity and reproducibility. The diagnostic performance of an artificial intelligence‐enabled liquid‐based cytology (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta obstetricia et gynecologica Scandinavica 2023-08, Vol.102 (8), p.1026-1033
Hauptverfasser: Xue, Peng, Xu, Hai‐Miao, Tang, Hong‐Ping, Wu, Wen‐Qing, Seery, Samuel, Han, Xiao, Ye, Hu, Jiang, Yu, Qiao, You‐Lin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1033
container_issue 8
container_start_page 1026
container_title Acta obstetricia et gynecologica Scandinavica
container_volume 102
creator Xue, Peng
Xu, Hai‐Miao
Tang, Hong‐Ping
Wu, Wen‐Qing
Seery, Samuel
Han, Xiao
Ye, Hu
Jiang, Yu
Qiao, You‐Lin
description Introduction Cytology‐based triaging is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but it suffers from subjectivity and a lack of sensitivity and reproducibility. The diagnostic performance of an artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) triage approach remains unclear. Here, we compared the clinical performance of AI‐LBC, human cytologists and HPV16/18 genotyping at triaging HPV‐positive women. Material and methods HPV‐positive women were triaged using AI‐LBC, human cytologists and HPV16/18 genotyping. Histologically confirmed cervical intraepithelial neoplasia grade 2/3 or higher (CIN2+/CIN3+) were accepted as thresholds for clinical performance assessments. Results Of the 3514 women included, 13.9% (n = 489) were HPV‐positive. The sensitivity of AI‐LBC was comparable to that of cytologists (86.49% vs 83.78%, P = 0.744) but substantially higher than HPV16/18 typing at detecting CIN2+ (86.49% vs 54.05%, P = 0.002). While the specificity of AI‐LBC was significantly lower than HPV16/18 typing (51.33% vs 87.17%, P 
doi_str_mv 10.1111/aogs.14611
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10377999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2826220099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4491-e495f043534aa09e219b548652cc3a9f0dcc759dc92d5e6e411a296d634006cf3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EokPLhgdAltggpBTf4ozZVKMKWqRKRWpha3mck-DKE6d20io7HgFekSfBmSnlsqg31rE_fT4-P0IvKDmkeb01oU2HVEhKH6EFlYQURFD2GC0IIbSQXKg99Cylq1yxSiyfoj1ecbokXC7Qj1VKkJLrWmzi4BpnnfHYdQN471roLGDozNpDjb27Hl3989v3tUm5tNMQfGgn3ISIh-hMO0tOP33JRB-SG9wN4Nuwge4dNrgP_ejN4EL3RxBDSrlKYOfz_Gwaxno6QE8a4xM8v9v30ecP7y-PT4uz85OPx6uzwgqhaAFClQ0RvOTCGKKAUbUuxVKWzFpuVENqa6tS1VaxugQJglLDlKzzOAiRtuH76Gjn7cf1BmoL3RCN1310GxMnHYzT_9507qtuw42mhFeVUiobXt8ZYrgeIQ1645LNgzMdhDFptmSSMUK26Kv_0KswxvznmRKcCKaUzNSbHbUdTYTmvhtK9By1nqPW26gz_PLv_u_R39lmgO6AW-dhekClV-cnFzvpL8ESu4M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2843042996</pqid></control><display><type>article</type><title>Assessing artificial intelligence enabled liquid‐based cytology for triaging HPV‐positive women: a population‐based cross‐sectional study</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Xue, Peng ; Xu, Hai‐Miao ; Tang, Hong‐Ping ; Wu, Wen‐Qing ; Seery, Samuel ; Han, Xiao ; Ye, Hu ; Jiang, Yu ; Qiao, You‐Lin</creator><creatorcontrib>Xue, Peng ; Xu, Hai‐Miao ; Tang, Hong‐Ping ; Wu, Wen‐Qing ; Seery, Samuel ; Han, Xiao ; Ye, Hu ; Jiang, Yu ; Qiao, You‐Lin</creatorcontrib><description>Introduction Cytology‐based triaging is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but it suffers from subjectivity and a lack of sensitivity and reproducibility. The diagnostic performance of an artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) triage approach remains unclear. Here, we compared the clinical performance of AI‐LBC, human cytologists and HPV16/18 genotyping at triaging HPV‐positive women. Material and methods HPV‐positive women were triaged using AI‐LBC, human cytologists and HPV16/18 genotyping. Histologically confirmed cervical intraepithelial neoplasia grade 2/3 or higher (CIN2+/CIN3+) were accepted as thresholds for clinical performance assessments. Results Of the 3514 women included, 13.9% (n = 489) were HPV‐positive. The sensitivity of AI‐LBC was comparable to that of cytologists (86.49% vs 83.78%, P = 0.744) but substantially higher than HPV16/18 typing at detecting CIN2+ (86.49% vs 54.05%, P = 0.002). While the specificity of AI‐LBC was significantly lower than HPV16/18 typing (51.33% vs 87.17%, P &lt; 0.001), it was significantly higher than cytologists at detecting CIN2+ (51.33% vs 40.93%, P &lt; 0.001). AI‐LBC reduced referrals to colposcopy by approximately 10%, compared with cytologists (51.53% vs 60.94%, P = 0.003). Similar patterns were also observed for CIN3+. Conclusions AI‐LBC has equivalent sensitivity and higher specificity compared with cytologists, with more efficient colposcopy referrals for HPV‐positive women. AI‐LBC could be particularly useful in regions where experienced cytologists are few in number. Further investigations are needed to determine triaging performance through prospective designs. Cytology triage is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but suffers from subjectivity, lack of reproducibility and sensitivity. In this study, authors investigated the performance of Artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) for triage of HPV‐positive women. Compared with cytologists, AI‐LBC showed equivalent sensitivity and higher specificity with more efficient colposcopy referrals for triage of HPV‐positive women.</description><identifier>ISSN: 0001-6349</identifier><identifier>EISSN: 1600-0412</identifier><identifier>DOI: 10.1111/aogs.14611</identifier><identifier>PMID: 37318036</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Artificial Intelligence ; Cellular biology ; Cervical cancer ; cervical cancer screening ; Colposcopy ; Cross-Sectional Studies ; cytology ; Early Detection of Cancer - methods ; Female ; Gynecology ; HPV triage ; Human papillomavirus ; Human papillomavirus 16 - genetics ; Human papillomavirus 18 - genetics ; Humans ; Original ; Pap smear ; Papillomavirus Infections - diagnosis ; Population-based studies ; Pregnancy ; Reproducibility of Results ; Triage - methods ; Uterine Cervical Dysplasia - pathology ; Uterine Cervical Neoplasms - pathology ; Womens health</subject><ispartof>Acta obstetricia et gynecologica Scandinavica, 2023-08, Vol.102 (8), p.1026-1033</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).</rights><rights>2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4491-e495f043534aa09e219b548652cc3a9f0dcc759dc92d5e6e411a296d634006cf3</citedby><cites>FETCH-LOGICAL-c4491-e495f043534aa09e219b548652cc3a9f0dcc759dc92d5e6e411a296d634006cf3</cites><orcidid>0000-0003-3002-8146</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377999/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377999/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37318036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xue, Peng</creatorcontrib><creatorcontrib>Xu, Hai‐Miao</creatorcontrib><creatorcontrib>Tang, Hong‐Ping</creatorcontrib><creatorcontrib>Wu, Wen‐Qing</creatorcontrib><creatorcontrib>Seery, Samuel</creatorcontrib><creatorcontrib>Han, Xiao</creatorcontrib><creatorcontrib>Ye, Hu</creatorcontrib><creatorcontrib>Jiang, Yu</creatorcontrib><creatorcontrib>Qiao, You‐Lin</creatorcontrib><title>Assessing artificial intelligence enabled liquid‐based cytology for triaging HPV‐positive women: a population‐based cross‐sectional study</title><title>Acta obstetricia et gynecologica Scandinavica</title><addtitle>Acta Obstet Gynecol Scand</addtitle><description>Introduction Cytology‐based triaging is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but it suffers from subjectivity and a lack of sensitivity and reproducibility. The diagnostic performance of an artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) triage approach remains unclear. Here, we compared the clinical performance of AI‐LBC, human cytologists and HPV16/18 genotyping at triaging HPV‐positive women. Material and methods HPV‐positive women were triaged using AI‐LBC, human cytologists and HPV16/18 genotyping. Histologically confirmed cervical intraepithelial neoplasia grade 2/3 or higher (CIN2+/CIN3+) were accepted as thresholds for clinical performance assessments. Results Of the 3514 women included, 13.9% (n = 489) were HPV‐positive. The sensitivity of AI‐LBC was comparable to that of cytologists (86.49% vs 83.78%, P = 0.744) but substantially higher than HPV16/18 typing at detecting CIN2+ (86.49% vs 54.05%, P = 0.002). While the specificity of AI‐LBC was significantly lower than HPV16/18 typing (51.33% vs 87.17%, P &lt; 0.001), it was significantly higher than cytologists at detecting CIN2+ (51.33% vs 40.93%, P &lt; 0.001). AI‐LBC reduced referrals to colposcopy by approximately 10%, compared with cytologists (51.53% vs 60.94%, P = 0.003). Similar patterns were also observed for CIN3+. Conclusions AI‐LBC has equivalent sensitivity and higher specificity compared with cytologists, with more efficient colposcopy referrals for HPV‐positive women. AI‐LBC could be particularly useful in regions where experienced cytologists are few in number. Further investigations are needed to determine triaging performance through prospective designs. Cytology triage is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but suffers from subjectivity, lack of reproducibility and sensitivity. In this study, authors investigated the performance of Artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) for triage of HPV‐positive women. Compared with cytologists, AI‐LBC showed equivalent sensitivity and higher specificity with more efficient colposcopy referrals for triage of HPV‐positive women.</description><subject>Artificial Intelligence</subject><subject>Cellular biology</subject><subject>Cervical cancer</subject><subject>cervical cancer screening</subject><subject>Colposcopy</subject><subject>Cross-Sectional Studies</subject><subject>cytology</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Gynecology</subject><subject>HPV triage</subject><subject>Human papillomavirus</subject><subject>Human papillomavirus 16 - genetics</subject><subject>Human papillomavirus 18 - genetics</subject><subject>Humans</subject><subject>Original</subject><subject>Pap smear</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Population-based studies</subject><subject>Pregnancy</subject><subject>Reproducibility of Results</subject><subject>Triage - methods</subject><subject>Uterine Cervical Dysplasia - pathology</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Womens health</subject><issn>0001-6349</issn><issn>1600-0412</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhi0EokPLhgdAltggpBTf4ozZVKMKWqRKRWpha3mck-DKE6d20io7HgFekSfBmSnlsqg31rE_fT4-P0IvKDmkeb01oU2HVEhKH6EFlYQURFD2GC0IIbSQXKg99Cylq1yxSiyfoj1ecbokXC7Qj1VKkJLrWmzi4BpnnfHYdQN471roLGDozNpDjb27Hl3989v3tUm5tNMQfGgn3ISIh-hMO0tOP33JRB-SG9wN4Nuwge4dNrgP_ejN4EL3RxBDSrlKYOfz_Gwaxno6QE8a4xM8v9v30ecP7y-PT4uz85OPx6uzwgqhaAFClQ0RvOTCGKKAUbUuxVKWzFpuVENqa6tS1VaxugQJglLDlKzzOAiRtuH76Gjn7cf1BmoL3RCN1310GxMnHYzT_9507qtuw42mhFeVUiobXt8ZYrgeIQ1645LNgzMdhDFptmSSMUK26Kv_0KswxvznmRKcCKaUzNSbHbUdTYTmvhtK9By1nqPW26gz_PLv_u_R39lmgO6AW-dhekClV-cnFzvpL8ESu4M</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Xue, Peng</creator><creator>Xu, Hai‐Miao</creator><creator>Tang, Hong‐Ping</creator><creator>Wu, Wen‐Qing</creator><creator>Seery, Samuel</creator><creator>Han, Xiao</creator><creator>Ye, Hu</creator><creator>Jiang, Yu</creator><creator>Qiao, You‐Lin</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3002-8146</orcidid></search><sort><creationdate>202308</creationdate><title>Assessing artificial intelligence enabled liquid‐based cytology for triaging HPV‐positive women: a population‐based cross‐sectional study</title><author>Xue, Peng ; Xu, Hai‐Miao ; Tang, Hong‐Ping ; Wu, Wen‐Qing ; Seery, Samuel ; Han, Xiao ; Ye, Hu ; Jiang, Yu ; Qiao, You‐Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4491-e495f043534aa09e219b548652cc3a9f0dcc759dc92d5e6e411a296d634006cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Artificial Intelligence</topic><topic>Cellular biology</topic><topic>Cervical cancer</topic><topic>cervical cancer screening</topic><topic>Colposcopy</topic><topic>Cross-Sectional Studies</topic><topic>cytology</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Gynecology</topic><topic>HPV triage</topic><topic>Human papillomavirus</topic><topic>Human papillomavirus 16 - genetics</topic><topic>Human papillomavirus 18 - genetics</topic><topic>Humans</topic><topic>Original</topic><topic>Pap smear</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Population-based studies</topic><topic>Pregnancy</topic><topic>Reproducibility of Results</topic><topic>Triage - methods</topic><topic>Uterine Cervical Dysplasia - pathology</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xue, Peng</creatorcontrib><creatorcontrib>Xu, Hai‐Miao</creatorcontrib><creatorcontrib>Tang, Hong‐Ping</creatorcontrib><creatorcontrib>Wu, Wen‐Qing</creatorcontrib><creatorcontrib>Seery, Samuel</creatorcontrib><creatorcontrib>Han, Xiao</creatorcontrib><creatorcontrib>Ye, Hu</creatorcontrib><creatorcontrib>Jiang, Yu</creatorcontrib><creatorcontrib>Qiao, You‐Lin</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta obstetricia et gynecologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xue, Peng</au><au>Xu, Hai‐Miao</au><au>Tang, Hong‐Ping</au><au>Wu, Wen‐Qing</au><au>Seery, Samuel</au><au>Han, Xiao</au><au>Ye, Hu</au><au>Jiang, Yu</au><au>Qiao, You‐Lin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing artificial intelligence enabled liquid‐based cytology for triaging HPV‐positive women: a population‐based cross‐sectional study</atitle><jtitle>Acta obstetricia et gynecologica Scandinavica</jtitle><addtitle>Acta Obstet Gynecol Scand</addtitle><date>2023-08</date><risdate>2023</risdate><volume>102</volume><issue>8</issue><spage>1026</spage><epage>1033</epage><pages>1026-1033</pages><issn>0001-6349</issn><eissn>1600-0412</eissn><abstract>Introduction Cytology‐based triaging is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but it suffers from subjectivity and a lack of sensitivity and reproducibility. The diagnostic performance of an artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) triage approach remains unclear. Here, we compared the clinical performance of AI‐LBC, human cytologists and HPV16/18 genotyping at triaging HPV‐positive women. Material and methods HPV‐positive women were triaged using AI‐LBC, human cytologists and HPV16/18 genotyping. Histologically confirmed cervical intraepithelial neoplasia grade 2/3 or higher (CIN2+/CIN3+) were accepted as thresholds for clinical performance assessments. Results Of the 3514 women included, 13.9% (n = 489) were HPV‐positive. The sensitivity of AI‐LBC was comparable to that of cytologists (86.49% vs 83.78%, P = 0.744) but substantially higher than HPV16/18 typing at detecting CIN2+ (86.49% vs 54.05%, P = 0.002). While the specificity of AI‐LBC was significantly lower than HPV16/18 typing (51.33% vs 87.17%, P &lt; 0.001), it was significantly higher than cytologists at detecting CIN2+ (51.33% vs 40.93%, P &lt; 0.001). AI‐LBC reduced referrals to colposcopy by approximately 10%, compared with cytologists (51.53% vs 60.94%, P = 0.003). Similar patterns were also observed for CIN3+. Conclusions AI‐LBC has equivalent sensitivity and higher specificity compared with cytologists, with more efficient colposcopy referrals for HPV‐positive women. AI‐LBC could be particularly useful in regions where experienced cytologists are few in number. Further investigations are needed to determine triaging performance through prospective designs. Cytology triage is commonly used to manage the care of women with positive human papillomavirus (HPV) results, but suffers from subjectivity, lack of reproducibility and sensitivity. In this study, authors investigated the performance of Artificial intelligence‐enabled liquid‐based cytology (AI‐LBC) for triage of HPV‐positive women. Compared with cytologists, AI‐LBC showed equivalent sensitivity and higher specificity with more efficient colposcopy referrals for triage of HPV‐positive women.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37318036</pmid><doi>10.1111/aogs.14611</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3002-8146</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6349
ispartof Acta obstetricia et gynecologica Scandinavica, 2023-08, Vol.102 (8), p.1026-1033
issn 0001-6349
1600-0412
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10377999
source MEDLINE; Wiley Online Library Open Access; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Artificial Intelligence
Cellular biology
Cervical cancer
cervical cancer screening
Colposcopy
Cross-Sectional Studies
cytology
Early Detection of Cancer - methods
Female
Gynecology
HPV triage
Human papillomavirus
Human papillomavirus 16 - genetics
Human papillomavirus 18 - genetics
Humans
Original
Pap smear
Papillomavirus Infections - diagnosis
Population-based studies
Pregnancy
Reproducibility of Results
Triage - methods
Uterine Cervical Dysplasia - pathology
Uterine Cervical Neoplasms - pathology
Womens health
title Assessing artificial intelligence enabled liquid‐based cytology for triaging HPV‐positive women: a population‐based cross‐sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A13%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20artificial%20intelligence%20enabled%20liquid%E2%80%90based%20cytology%20for%20triaging%20HPV%E2%80%90positive%20women:%20a%20population%E2%80%90based%20cross%E2%80%90sectional%20study&rft.jtitle=Acta%20obstetricia%20et%20gynecologica%20Scandinavica&rft.au=Xue,%20Peng&rft.date=2023-08&rft.volume=102&rft.issue=8&rft.spage=1026&rft.epage=1033&rft.pages=1026-1033&rft.issn=0001-6349&rft.eissn=1600-0412&rft_id=info:doi/10.1111/aogs.14611&rft_dat=%3Cproquest_pubme%3E2826220099%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2843042996&rft_id=info:pmid/37318036&rfr_iscdi=true